EUVIMEDEUVIMED entdecken
Crossref

Co-Delivery of Astaxanthin and si TGF-β 1 via Ionizable Liposome Nanoparticles for Improved Idiopathic Pulmonary Fibrosis Therapy

Xiaoling Cao, Chenggong Yu, Shengnan Cheng, Yuhan Wang, Zhijun Zhang iD, Jie Huang iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c01953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Xiaoling Cao und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Nano-Tech and Nano-Bionics, University of Science and Technology of China institution, Hefei 230026, China. Hauptthemen laut MEDLINE: Liposomes, Transforming Growth Factor beta1, Nanoparticles, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Science and Technology Program of Suzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesTransforming Growth Factor beta1NanoparticlesIdiopathic Pulmonary FibrosisRNA, Small InterferingAnimalsXanthophyllsMiceHumansReactive Oxygen SpeciesMaleApoptosisDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

astaxanthincombination therapyidiopathic pulmonary fibrosisliposome nanoparticlessmall interfering RNA

Substanzen

LiposomesXanthophyllsTransforming Growth Factor beta1astaxanthineRNA, Small InterferingReactive Oxygen Species

Autor:innen und Institutionen

  • School of Nano-Tech and Nano-Bionics, University of Science and Technology of China institution, Hefei 230026, China.
  • Organoid Innovation Center, CAS Key Laboratory of Nano-Bio Interface, Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-bionics, Chinese Academy of Sciences, Suzhou 215123, China.

ORCID-Profile: Zhijun Zhang, Jie Huang

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Science and Technology Program of Suzhou
  • Jiangsu Funding Program for Excellent Postdoctoral Talent
  • CAS-VPST Silk Road Science Fund 2021

Zitieren

APA

Cao, X., Yu, C., Cheng, S., Wang, Y., Zhang, Z., & Huang, J. (2024). Co-Delivery of Astaxanthin and si TGF-β 1 via Ionizable Liposome Nanoparticles for Improved Idiopathic Pulmonary Fibrosis Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c01953

Vancouver

Cao X, Yu C, Cheng S, Wang Y, Zhang Z, Huang J. Co-Delivery of Astaxanthin and si TGF-β 1 via Ionizable Liposome Nanoparticles for Improved Idiopathic Pulmonary Fibrosis Therapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c01953

BibTeX
@article{Cao2024,
  author = {Cao, Xiaoling and Yu, Chenggong and Cheng, Shengnan and Wang, Yuhan and Zhang, Zhijun and Huang, Jie},
  title = {Co-Delivery of Astaxanthin and si TGF-β 1 via Ionizable Liposome Nanoparticles for Improved Idiopathic Pulmonary Fibrosis Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c01953}
}
Kostenlos starten →